Growth Metrics

Gilead Sciences (GILD) Profit After Tax Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.25%
Dec 31, 2025 7.08%
Sep 30, 2025 53.94%
Jun 30, 2025 20.94%
Mar 31, 2025 -3.08%
Dec 31, 2024 -7.89%
Sep 30, 2024 25.17%
Jun 30, 2024 -3.01%
Mar 31, 2024 -32.68%
Dec 31, 2023 240.69%
Sep 30, 2023 0.71%
Jun 30, 2023 -10.47%
Mar 31, 2023 -8.07%
Dec 31, 2022 19.34%
Sep 30, 2022 -7.98%
Jun 30, 2022 -18.06%
Mar 31, 2022 -62.90%
Dec 31, 2021 -35.09%
Sep 30, 2021 -4.86%
Jun 30, 2021 -15.33%
Mar 31, 2021 -13.55%
Dec 31, 2020 -19.84%
Sep 30, 2020 -40.16%
Jun 30, 2020 -22.36%
Mar 31, 2020 -18.71%
Dec 31, 2019 -4.93%
Sep 30, 2019 -19.41%
Jun 30, 2019 -12.46%
Mar 31, 2019 -2.37%
Dec 31, 2018 -67.17%
Sep 30, 2018 21.75%
Jun 30, 2018 18.64%
Mar 31, 2018 16.33%
Dec 31, 2017 -47.81%
Sep 30, 2017 32.22%
Jun 30, 2017 33.99%
Mar 31, 2017 43.92%
Dec 31, 2016 36.26%
Sep 30, 2016 49.72%
Jun 30, 2016 36.33%
Mar 31, 2016 40.52%
Dec 31, 2015 49.40%
Sep 30, 2015 45.52%
Jun 30, 2015 44.57%
Mar 31, 2015 38.35%
Dec 31, 2014 34.06%
Sep 30, 2014 32.33%
Jun 30, 2014 44.95%
Mar 31, 2014 30.58%